United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

fdc international ltd - brimonidine tartrate - eye drops - 2mg/1ml

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fdc eco solutions pty ltd - metsulfuron-methyl - water dispersible granule - metsulfuron-methyl urea-sulfonyl active 600.0 g/kg - herbicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fdc eco solutions pty ltd - glufosinate-ammonium - soluble concentrate - glufosinate-ammonium organophosphorus-phosphinic ac active 200.0 g/l - herbicide

India - English - Central Drugs Standard Control Organization

fdc(lumina) - amoxycillin,clavulanic acid - f. d-syr - 400,57;mg - 30ml

India - English - Central Drugs Standard Control Organization

fdc(lumina) - amoxycillin,clavulanic acid - tab - 250,125;mg - 6

India - English - Central Drugs Standard Control Organization

fdc(lumina) - amoxycillin,clavulanic acid - tab - 500,125;mg - 6

United States - English - NLM (National Library of Medicine)

fdc limited - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: * efficacy for this organism was studied in fewer than 10 infections ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication.

United States - English - NLM (National Library of Medicine)

fdc limited - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: corneal ulcers: pseudomonas aeruginosa serratia marcescens * staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae streptococcus (viridans group) * conjunctivitis: haemophilus influenzae staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae *efficacy for this organism was studied in fewer than 10 infections. a history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use. a history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

fdc international ltd - timolol maleate - eye drops - 2.5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

fdc international ltd - timolol maleate - eye drops - 5mg/1ml